Australia markets closed

Shenzhen YHLO Biotech Co., Ltd. (688575.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
23.98+0.03 (+0.13%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,824,428
2,053,101
3,980,757
1,177,896
999,007
Cost of revenue
681,758
886,811
1,832,537
508,331
421,554
Gross profit
1,142,670
1,166,291
2,148,220
669,565
577,453
Operating expenses
Research development
341,347
317,182
240,314
130,742
103,177
Selling general and administrative
442,167
451,379
540,552
242,660
176,189
Total operating expenses
855,709
849,990
874,838
417,563
299,925
Operating income or loss
286,960
316,301
1,273,382
252,002
277,529
Interest expense
6,435
6,253
8,407
11,221
13,171
Income before tax
314,244
334,109
1,186,492
227,756
241,503
Income tax expense
46,848
54,909
165,218
23,910
33,544
Income from continuing operations
267,396
279,200
1,021,274
203,847
207,958
Net income
339,811
355,015
1,012,120
204,748
210,532
Net income available to common shareholders
339,811
355,015
1,012,120
204,748
210,532
Basic EPS
0.75
0.63
1.79
0.38
0.41
Diluted EPS
0.74
0.62
1.78
0.38
0.41
Basic average shares
567,836
563,515
565,430
538,809
508,182
Diluted average shares
571,013
572,604
568,607
538,809
508,182